Concepedia

Mariela Sivina

MS

31

Publications

3.3K

Citations

22

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

Broad Institute

University of California San Diego

National Institutes of Health

Mariela Sivina is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2006–2022

31

Publications

31

The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

Julia Hoellenriegel, Sarah Meadows, Mariela Sivina et al. · Blood · 2011 · 547 citations · Full text

Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition

Jan A. Burger, Dan A. Landau, Amaro Taylor‐Weiner et al. · Nature Communications · 2016 · 338 citations · Full text

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

Antonina V. Kurtova, Kumudha Balakrishnan, Rong Chen et al. · Blood · 2009 · 315 citations · Full text

B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406

Maite P. Quiroga, Kumudha Balakrishnan, Antonina V. Kurtova et al. · Blood · 2009 · 238 citations · Full text

Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia

Jan A. Burger, Mariela Sivina, Nitin Jain et al. · Blood · 2018 · 219 citations · Full text

Rows per page

1–5 of 31